Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maruzzo

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2015
More on sunitinib 2 weeks on/1 week off schedule: the Rainbow analysisU Basso, M Maruzzo
Current Medicinal Chemistry|January 3, 2013
Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomasM Maruzzo, M Rastrelli, F Lumachi, et al.
Current Medicinal Chemistry|January 3, 2013
Treatment of estrogen receptor-positive breast cancerF Lumachi, A Brunello, M Maruzzo, et al.
Current Medicinal Chemistry|July 16, 2011
Malignant hypercalcemiaU Basso, M Maruzzo, A Roma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2012
Safety and activity of sunitinib in elderly patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter studyA Brunello, U Basso, C Sacco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 2, 2020
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapyG L Banna, R Di Quattro, L Malatino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2016
Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomesM Rastrelli, S Mocellin, R Stramare, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO groupA Rametta, S Ferri, M Maruzzo, et al.
ESMO Open|May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohortG Fornarini, S E Rebuzzi, G L Banna, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2015
More on sunitinib 2 weeks on/1 week off schedule: the Rainbow analysisU Basso, M Maruzzo
Current Medicinal Chemistry|January 3, 2013
Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomasM Maruzzo, M Rastrelli, F Lumachi, et al.
Current Medicinal Chemistry|January 3, 2013
Treatment of estrogen receptor-positive breast cancerF Lumachi, A Brunello, M Maruzzo, et al.
Current Medicinal Chemistry|July 16, 2011
Malignant hypercalcemiaU Basso, M Maruzzo, A Roma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2012
Safety and activity of sunitinib in elderly patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter studyA Brunello, U Basso, C Sacco, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 2, 2020
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapyG L Banna, R Di Quattro, L Malatino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2016
Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomesM Rastrelli, S Mocellin, R Stramare, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO groupA Rametta, S Ferri, M Maruzzo, et al.
ESMO Open|May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohortG Fornarini, S E Rebuzzi, G L Banna, et al.
Pageof 2